188 results
8-K
EX-99.1
NEO
Neogenomics Inc.
15 Apr 21
Other Events
4:40pm
Employee Engagement Employee Retention88% Customer Satisfaction Client Retention95% Shareholder Satisfaction Achieve ResultsPlan Satisfaction Model
8-K
EX-2.2
NEO
Neogenomics Inc.
31 Dec 15
Entry into a Material Definitive Agreement
12:00am
that is three (3) Business Days after the satisfaction or written waiver of the Closing Conditions or on such other date as the Parties may agree … ”) and that the Effective Time on the New Closing Date shall be 12:01 am, subject to the satisfaction or written waiver of the Closing Conditions and to all
8-K
EX-99.1
NEO
Neogenomics Inc.
17 Apr 20
Improving Patient Care 2019 Annual Report
4:55pm
and satisfaction, and a steady increase in market share. Strategically, we continued to fortify our market position as the leading oncology-lab … company. Satisfaction Model Employee Engagement Customer Satisfaction Shareholder Satisfaction Employee Retention85% Client Retention95% Achieve
8-K
EX-99.1
NEO
Neogenomics Inc.
25 Feb 21
Regulation FD Disclosure
5:08pm
class culture drives high customer satisfaction and strong brand recognition Robust and expanding global oncology testing and information market … Not at all likely Neutral Extremely likely Detractor Passive Promoter 7% 20% 73% 0 50 100-100 -50 +66 NPS Satisfaction Model Employee Engagement
8-K
EX-99.1
NEO
Neogenomics Inc.
6 May 21
Regulation FD Disclosure
5:07pm
satisfaction and strong brand recognition Robust and expanding global oncology testing and information market Clinical Services 85% Pharma & Informatics … Extremely likely Detractor Passive Promoter 7% 20% 73% 0 50 100-100 -50 +66 NPS Satisfaction Model Employee Engagement Employee Retention Customer
8-K
EX-99.1
n5vl3ny lq2i
5 Jan 21
Other Events
4:01pm
8-K
EX-99.1
me5509
8 Jun 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
z8kb8javhzve
20 May 19
Regulation FD Disclosure
4:37pm
8-K
EX-99.1
hayi0jm9ye0sij7w
4 May 20
NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
5:18pm
8-K
EX-99.1
uwngiy7zs9c7g
10 Aug 21
Regulation FD Disclosure
5:09pm
8-K
EX-2.1
zv2 w5nw4nd6xk
5 May 21
NeoGenomics to Acquire Inivata - Combining Best-In-Class Liquid Biopsy
7:30am
8-K
EX-99.1
4bbr20hp7tp6u6vo8
2 Aug 19
Regulation FD Disclosure
12:41pm
8-K
um63o906zsa
24 Mar 21
NeoGenomics Agrees to Acquire Trapelo Health
4:45pm
8-K/A
5loezg5fiielfntj 41
22 Mar 02
Changes in registrant's certifying accountant
12:00am
8-K
EX-99.1
dd3j hxdzg
12 Dec 18
NeoGenomics Announces Pricing on Secondary Offering of
4:18pm
S-8
EX-99.1
hw4m jw62e28im75yn
12 Aug 22
Registration of securities for employees
5:09pm
8-K
EX-99.2
c0xs66 ee
30 Apr 20
NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes
12:00am
8-K
7cyem 7ibytoi
31 Mar 00
Report of Change In Accountants
12:00am
10QSB
s15fa 0pt
22 May 00
Quarterly report (small business)
12:00am
8-K
EX-99.1
m719rcan16m51qj7g
22 May 19
NeoGenomics Announces Pricing on Public Offering of Common Stock
8:15am